NCT04717700: Phase 2: Selinexor With Alternating Bortezomib or Lenalidomide Plus Dex in TIE NDMM
Patient Symposium - MCRT Webcast Myeloma Crowd Round Table, 04/10/2021
NCT04798586: Phase 1: MAGNETISMM-2: Study of Elranatamab (PF-06863135) in Japanese Patients Myeloma
NCT04722146: Phase 1b - Teclistamab With Other Anticancer Therapies in Participants With Myeloma
NCT04850846: Phase 2: Investigation of Metformin for the Prevention of Progression of Precursor MM
THE MMRF - Managing Myeloma Resource Brochure
THE MMRF - Multiple Myeloma Treatment Overview
NCCN GUIDELINES FOR PATIENTS: Immunotherapy Side Effects: CAR T-Cell Therapy
NCT04892446: Phase 2: Study of Magrolimab Combinations in Participants With Relapsed/Refractory MM
NCT04920084: A Study of a Plant-Based Diet in People With MGUS / Smoldering Myeloma - NUTRIVENTION
NCT04756726: Phase 1/2: CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma
THE MMRF - Multiple Myeloma Disease Overview
The Binding Site: Introducing the iStopMM Trial
NCT04773522: Phase 1 - JNJ-64407564 in Japanese Participants With Relapsed or Refractory Myeloma
NCT04827563: Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib
NCT04822337: Phase 1/2 - Study of Carfilzomib, Len, Dex & Belantamab Mafodotin in Multiple Myeloma
NCT04735575: Phase 1/2: Study of EMB-06 in Participants With Relapsed or Refractory Myeloma
NCT04855929: Phase 1: Safety and Therapeutic Activity of ANV419 in RRMM - ANV419-001
NCT04814615: Phase 2: A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma
THE MMRF - Multiple Myeloma Caregiver Guide
Patient Symposium - MCRT Webcast Myeloma Crowd Round Table, 01/30/2021
HealthTree University Myeloma: What are the different catheters and ports?
Dana-Farber's 2020 Multiple Myeloma Patient Symposium - Current and Future Treatment of Myeloma
NCT04688853: Phase 1 - A Study to Investigate the Safety and Efficacy of TEG002 in RRMM